News Features Hopes and Hype Await New Coronary Revascularization Appropriate Use Criteria in 2016 Caitlin E. Cox March 21, 2016
News Daily News Scoring System Simplifies Risk Assessment for Sudden Cardiac Death After NSTE ACS L.A. McKeown March 18, 2016
News Daily News Amid Soaring CAD in China, Rates of Catheterization and PCI Begin to Mount Leah Lawrence March 18, 2016
News Daily News FDA Panel Overwhelmingly Supports Absorb Bioresorbable Stent Michael O'Riordan March 16, 2016
News Daily News Suboptimal Care for Women With CAD Linked to Higher Long-Term Mortality Caitlin E. Cox February 28, 2016
News Opinion Conversations in Cardiology Conversations in Cardiology: Post-PCI Clopidogrel in CHAMPION PHOENIX Trial of Cangrelor February 08, 2016
News Daily News Leaving Significant Stenoses Untreated After PCI May Worsen 1-Year Outcomes: SCAAR Data Todd Neale February 01, 2016
News Daily News Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond December 23, 2015
News Daily News Ezetimibe Fails to Garner Support for CV- Event Reduction Claim From FDA Advisory Committee Michael O'Riordan December 15, 2015
News Industry News Regeneron and Sanofi Announce 18,000-Patient ODYSSEY OUTCOMES Trial of Praluent® Injection Fully Enrolled November 23, 2015
News Daily News Post-PCI Neurological Events, Though Infrequent, Continue to Carry ‘Abysmal’ Consequences Todd Neale November 22, 2015
News Daily News Los Expertos Debaten los Tratamientos basados en las Directrices en Pacientes con Enfermedad Multivaso L.A. McKeown November 17, 2015
News Daily News Experts Debate Merits of Guideline-Directed Care for Patients With Multivessel Disease L.A. McKeown November 17, 2015
Presentation Effect of PCI on Long-term Survivalin Patients With Stable Ischemic Heart Disease Presenter: Steven P. Sedlis November 10, 2015
News Daily News COURAGE at 15 Years: Still No Survival Advantage for PCI L.A. McKeown November 10, 2015
Presentation TCT 2015 Debate: Should Most Patients With Stable Ischemic Heart Disease, Moderate or Greater Ischemia, and Controllable Symptoms Undergo Revascularization? Yes, an Evidence-Based Position! Presenter: Kevin J. Beatt, Craig R. Smith, Gregg W. Stone October 11, 2015
Presentation TCT 2015 Debate: Should Most Patients With Stable Ischemic Heart Disease, Moderate or Greater Ischemia, and Controllable Symptoms Undergo Revascularization? The Data Says Not as a First-Line Therapy! Presenter: Kevin J. Beatt, Craig R. Smith, David J. Maron October 11, 2015
News Conference News ESC 2015 ESC Congress 2015: Presentations Sift Clinical Wheat From Chaff September 09, 2015